Heart & Vascular News

Approval by the U.S. Food and Drug Administration (FDA) of fenestrated endovascular stent grafts allows vascular surgeons at the Washington University and Barnes-Jewish Heart & Vascular Center to be among few in the nation providing a new alternative to patients diagnosed with complex abdominal aortic aneurysms (AAA).

The Washington University and Barnes-Jewish Hospital Heart and Vascular Center is a 2012 recipient of the American Heart Association’s (AHA) Mission: Lifeline Gold Award. The award recognizes the success of Barnes-Jewish and their physician partners at Washington University School of Medicine in providing quality care to heart attack patients. Barnes-Jewish is the only St. Louis area hospital to receive this recognition.

While multiple treatment options exist to treat PAD, new therapies at the Washington University and Barnes-Jewish Heart & Vascular Center are giving patients a minimally-invasive option. Endovascular therapy, using balloons and stents, is being used in a growing number of patients.